Skip to content
healthcare.dev

Vivotif

NDC 50632-016, Salmonella typhi Ty21a, capsule, coated, from Bavarian Nordic A/S.

Product NDC
50632-016
Status
Listed
Labeler
Bavarian Nordic A/S
Dosage form
CAPSULE, COATED
Route
ORAL
Product type
VACCINE
Marketing category
BLA
Application
BLA103123
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50632-016 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SALMONELLA TYPHI TY21A LIVE ANTIGEN6000000000 [CFU]/1

Pharmacologic classes

Actively Acquired Immunity [PE]; Live Attenuated Salmonella Typhi Vaccine [EPC]; Vaccines, Attenuated [CS]; Vaccines, Typhoid [CS]

Package NDCNDC-11Package
50632-016-02506320016021 BLISTER PACK in 1 CARTON (50632-016-02) / 4 CAPSULE, COATED in 1 BLISTER PACK (50632-016-04)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 50632-016 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50632-016 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50632-016. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.